Biodesix, Inc. R&D Expenses

R&D Expenses of BDSX for past 10 years: annual, quarterly and twelve month trailing (TTM) including R&D Expenses growth rates and interactive chart. Research and development (R&D) expenses are associated with the research and development of a company's goods or services. A company generally incurs R&D expenses in the process of finding and creating new products or services. It is an operating expense and can be deducted from a company's income taxes.


Highlights and Quick Summary

  • R&D Expenses for the quarter ending September 30, 2022 was $2.97 Million (a -11.63% decrease compared to previous quarter)
  • Year-over-year quarterly R&D Expenses increased by 4.14%
  • Annual R&D Expenses for 2021 was $12.8 Million (a 18.22% increase from previous year)
  • Annual R&D Expenses for 2020 was $10.8 Million (a 3.34% increase from previous year)
  • Annual R&D Expenses for 2019 was $10.5 Million (a 27.85% increase from previous year)
  • Twelve month R&D Expenses ending September 30, 2022 was $12.4 Million (a -2.54% decrease compared to previous quarter)
  • Twelve month trailing R&D Expenses decreased by -3.13% year-over-year
Trailing R&D Expenses for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$12.4 Million $12.7 Million $12.7 Million $12.8 Million
Visit stockrow.com/BDSX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical R&D Expenses of Biodesix, Inc.

Most recent R&D Expensesof BDSX including historical data for past 10 years.

Interactive Chart of R&D Expenses of Biodesix, Inc.

Biodesix, Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $2.97 $3.36 $3.21
2021 $2.85 $3.29 $3.32 $3.32 $12.79
2020 $3.11 $2.71 $2.11 $2.9 $10.82
2019 $2.5 $2.36 $10.47
2018 $8.19

Business Profile of Biodesix, Inc.

Sector: Healthcare
Industry: Diagnostics & Research